ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 /Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company ...

In 2019, a meta-analysis suggested that the risk of coronary morbidity was 30% higher among Sjögren's patients than it was ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

A study finds target lesion failure in 1 in 5 patients with STEMI within 10 years of primary percutaneous coronary ...

Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

A recent study concluded that hemorrhagic myocardial infarction (hMI) remains a common and clinically significant ...

Hulk Hogan’s widow, Sky, has flat-out denied Ric Flair’s bombshell claims that her husband died from “street drugs.” Flair, ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

Medical experts are warning that hypertension rates are climbing among Nigeria's youth, fueled by lifestyle risks and limited ...

There are improved cardiovascular outcomes associated with semaglutide therapy in patients with overweight or obesity without diabetes.

"I was sitting at home reading a book at 11 p.m. when I suddenly felt discomfort, nausea, and pain." Kim Sangwook (55), ...

ASCVD Risk Estimator Plus and PREVENT calculator would have classified many patients as low risk 48 hours before MI.